Panacea Biotec Limited (PANACEABIO.BO)
INR 465.0
(2.69%)
INR 465.0
(2.69%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 5.51 Billion | 4.56 Billion | 6.59 Billion | 6.17 Billion | 5.37 Billion | 4.52 Billion |
| Cost of Revenue | 4.16 Billion | 2.78 Billion | 3 Billion | 2.28 Billion | 1.74 Billion | 2.02 Billion |
| Gross Profit | 1.35 Billion | 1.78 Billion | 3.59 Billion | 3.89 Billion | 3.62 Billion | 2.49 Billion |
| Operating Expenses | 1.99 Billion | 2.83 Billion | 4.11 Billion | 3.52 Billion | 3.2 Billion | 3.61 Billion |
| Selling, General and Administrative Expenses | 1.99 Billion | 389.8 Million | 553.39 Million | 502.75 Million | 455.28 Million | 437.92 Million |
| Research and Development Expenses | - | 139.13 Million | 105.09 Million | 125.62 Million | 205.13 Million | 157.73 Million |
| Other Expenses | 258 Million | 33.43 Million | 33.97 Million | 20.16 Million | 8.66 Million | 20.85 Million |
| Cost and Expenses | 6.03 Billion | 5.62 Billion | 7.11 Billion | 5.8 Billion | 4.95 Billion | 5.64 Billion |
| Operating Income | -309.7 Million | -1.05 Billion | -537.05 Million | 327.85 Million | 115.67 Million | -1.17 Billion |
| Interest Expense | 35.8 Million | 38.03 Million | 1.79 Billion | 1.84 Billion | 1.73 Billion | 849.69 Million |
| Income Tax Expense | 29.82 Million | 465.5 Million | 3.71 Billion | 19.57 Million | 166.4 Million | 77.07 Million |
| Earnings before Tax | 14.8 Million | 128.05 Million | 14.49 Billion | -1.44 Billion | -1.71 Billion | 486.15 Million |
| Net Income | -11.73 Million | -332.37 Million | 10.78 Billion | -1.47 Billion | -1.94 Billion | 377.27 Million |
| Earnings Per Share Basic | -0.19 | -5.43 | 176.05 | -24.11 | -31.72 | 6.16 |
| Earnings Per Share Diluted | -0.19 | -5.43 | 176.05 | -24.11 | -31.72 | 6.16 |
| Weighted Average Shares Outstanding | 61.57 Million | 61.25 Million | 61.25 Million | 61.25 Million | 61.25 Million | 61.25 Million |
| Weighted Average Shares Outstanding (Diluted) | 61.57 Million | 61.25 Million | 61.25 Million | 61.25 Million | 61.25 Million | 61.25 Million |
| Gross Margin | 0.25 | 0.39 | 0.54 | 0.63 | 0.68 | 0.55 |
| EBIT Margin | -0.04 | -0.11 | -0.00 | 0.14 | 0.17 | -0.20 |
| Profit Margin | -0.00 | -0.07 | 1.64 | -0.24 | -0.36 | 0.08 |
| EBITDA | -200.6 Million | 563.65 Million | 16.73 Billion | 866.06 Million | 456.49 Million | 2.07 Billion |
| Earnings Before Tax Margin | -0.06 | -0.23 | -0.08 | 0.05 | 0.02 | -0.26 |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 1.15 Billion | 5.59 Billion | 1.36 Billion | 1.5 Billion | 1.43 Billion | 1.29 Billion |
| Cost of Revenue | 879.5 Million | 4.16 Billion | 969.9 Million | 673.2 Million | 581.9 Million | 548.6 Million |
| Gross Profit | 277.7 Million | 1.42 Billion | 394.7 Million | 831.8 Million | 848.3 Million | 743.3 Million |
| Operating Expenses | 504.9 Million | 1.99 Billion | 543.2 Million | 924.4 Million | 977 Million | 941.2 Million |
| Selling, General and Administrative Expenses | 504.9 Million | - | 543.2 Million | 456.8 Million | 508.7 Million | 486.7 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 38 Million | 258 Million | 108.1 Million | 56.8 Million | 32.3 Million | 60.8 Million |
| Cost and Expenses | 1.38 Billion | 6.15 Billion | 1.51 Billion | 1.59 Billion | 1.55 Billion | 1.48 Billion |
| Operating Income | -227.2 Million | -567.7 Million | -148.5 Million | -35.8 Million | -128.7 Million | -197.9 Million |
| Interest Expense | 8.7 Million | 35.8 Million | 8.2 Million | 8.5 Million | 9.1 Million | 10 Million |
| Income Tax Expense | -11.7 Million | 29.8 Million | -1.3 Million | 5.5 Million | 5.1 Million | 20.5 Million |
| Earnings before Tax | -170.5 Million | 14.8 Million | -21.2 Million | -16.5 Million | -77.8 Million | 130.3 Million |
| Net Income | -158 Million | -11.7 Million | -14.3 Million | -22 Million | -82.9 Million | 109.8 Million |
| Earnings Per Share Basic | -2.58 | - | -0.23 | -0.36 | -1.35 | 1.78 |
| Earnings Per Share Diluted | -2.58 | - | -0.23 | -0.36 | -1.35 | 1.78 |
| Weighted Average Shares Outstanding | 61.25 Million | 61.57 Million | 61.25 Million | 61.25 Million | 61.25 Million | 61.25 Million |
| Weighted Average Shares Outstanding (Diluted) | 61.25 Million | 61.57 Million | 61.25 Million | 61.25 Million | 61.25 Million | 61.25 Million |
| Gross Margin | 0.24 | 0.26 | 0.29 | 0.55 | 0.59 | 0.58 |
| EBIT Margin | -0.12 | - | -0.04 | 0.04 | -0.00 | -0.03 |
| Profit Margin | -0.14 | -0.00 | -0.01 | -0.01 | -0.06 | 0.08 |
| EBITDA | -139.9 Million | - | -60.4 Million | 55.3 Million | -3.3 Million | -42.3 Million |
| Earnings Before Tax Margin | -0.20 | -0.10 | -0.11 | -0.02 | -0.09 | -0.15 |
6301
8898
DMKPQ
5133
PES
DNLI